4.84
Schlusskurs vom Vortag:
$4.8378
Offen:
$4.9
24-Stunden-Volumen:
2,938
Relative Volume:
0.15
Marktkapitalisierung:
$9.29M
Einnahmen:
$7.88M
Nettoeinkommen (Verlust:
$-69.20M
KGV:
-2.6448
EPS:
-1.83
Netto-Cashflow:
$-69.73M
1W Leistung:
-8.68%
1M Leistung:
-13.88%
6M Leistung:
-45.27%
1J Leistung:
-63.34%
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie BOLT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BOLT
Bolt Biotherapeutics Inc
|
4.84 | 9.56M | 7.88M | -69.20M | -69.73M | -1.83 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-03-02 | Eingeleitet | Guggenheim | Buy |
2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
2021-03-02 | Eingeleitet | Stifel | Buy |
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
Is Bolt Biotherapeutics Inc. likely to announce a buybackWeekly Investment Report & Pattern Based Trade Signal System - khodrobank.com
Understanding Bolt Biotherapeutics Inc.’s price movementJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Will Bolt Biotherapeutics Inc. price bounce be sustainableJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Bolt Biotherapeutics stock price target cut to $6 from $20 at Leerink Partners - Investing.com
What’s the recovery path for long term holders of Bolt Biotherapeutics Inc.2025 Earnings Impact & High Conviction Trade Alerts - Newser
Using data filters to optimize entry into Bolt Biotherapeutics Inc.Market Trend Review & Free Technical Confirmation Trade Alerts - Newser
Analyzing drawdowns of Bolt Biotherapeutics Inc. with statistical toolsJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Chart overlay techniques for tracking Bolt Biotherapeutics Inc.Global Markets & AI Forecast for Swing Trade Picks - Newser
Does Bolt Biotherapeutics Inc. qualify in momentum factor screeningEarnings Performance Report & Free Community Supported Trade Ideas - Newser
Smart tools for monitoring Bolt Biotherapeutics Inc.’s price action2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
Price momentum metrics for Bolt Biotherapeutics Inc. explainedM&A Rumor & Technical Entry and Exit Alerts - Newser
Can machine learning forecast Bolt Biotherapeutics Inc. recoveryAnalyst Downgrade & Risk Controlled Daily Plans - Newser
How to track smart money flows in Bolt Biotherapeutics Inc.M&A Rumor & AI Forecasted Stock Moves - Newser
How sentiment analysis helps forecast Bolt Biotherapeutics Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - Newser
Key resistance and support levels for Bolt Biotherapeutics Inc.July 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Best data tools to analyze Bolt Biotherapeutics Inc. stock2025 Market Outlook & Capital Efficient Trade Techniques - Newser
Is a relief rally coming for Bolt Biotherapeutics Inc. holdersGlobal Markets & Stock Timing and Entry Methods - Newser
What Fibonacci levels say about Bolt Biotherapeutics Inc. rebound2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Does Bolt Biotherapeutics Inc. have consistent dividend growthTrade Entry Report & Fast Entry Momentum Alerts - khodrobank.com
Can a trend reversal in Bolt Biotherapeutics Inc. lead to recoveryWeekly Stock Summary & Consistent Growth Equity Picks - Newser
RSI and MACD Indicate Shift in Bolt Biotherapeutics Inc. Sentiment getLinesFromResByArray error: size == 0 - thegnnews.com
Applying chart zones and confluence areas to Bolt Biotherapeutics Inc.Stock Surge & Low Risk High Reward Trade Ideas - Newser
Is Bolt Biotherapeutics Inc. stock forming a cup and handle2025 Top Gainers & Weekly Breakout Watchlists - khodrobank.com
How to forecast Bolt Biotherapeutics Inc. trends using time series2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
What is Bolt Biotherapeutics Inc. s P E ratio telling us2025 Earnings Impact & Daily Growth Stock Investment Tips - khodrobank.com
What is the dividend yield of Bolt Biotherapeutics Inc.2025 Price Targets & Smart Investment Allocation Tips - khodrobank.com
Institutional scanner results for Bolt Biotherapeutics Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - Newser
What recovery options are there for Bolt Biotherapeutics Inc.2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Trend analysis for Bolt Biotherapeutics Inc. this weekWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Bolt Biotherapeutics Inc. Inches Toward Key Resistance — Will It Break getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Bolt Biotherapeutics Inc. forming a bottoming baseJuly 2025 Outlook & Reliable Intraday Trade Plans - Newser
Quantitative breakdown of Bolt Biotherapeutics Inc. recent movePortfolio Update Report & Low Risk Investment Opportunities - Newser
Is Bolt Biotherapeutics Inc. Starting a New Uptrend getLinesFromResByArray error: size == 0 - newsyoung.net
What’s the profit margin of Bolt Biotherapeutics Inc. getLinesFromResByArray error: size == 0 - sisain.net
Should you hold or exit Bolt Biotherapeutics Inc. nowJuly 2025 Patterns & Entry and Exit Point Strategies - Newser
Identifying reversal signals in Bolt Biotherapeutics Inc.Quarterly Profit Review & Long Hold Capital Preservation Plans - Newser
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bolt Biotherapeutics Inc-Aktie (BOLT) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Quinn William P. | President, CEO and CFO |
Dec 16 '24 |
Buy |
0.50 |
2,500 |
1,241 |
41,272 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):